Patents by Inventor Saba Valadkhan

Saba Valadkhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9308218
    Abstract: A method of treating a BORG expressing cancer includes administering a therapeutically effective amount of at least one BORG inhibiting agent to the BORG overexpressing cancer cells of the subject.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 12, 2016
    Assignee: Case Western Reserve University
    Inventor: Saba Valadkhan
  • Publication number: 20140275217
    Abstract: A method of treating a BORG expressing cancer includes administering a therapeutically effective amount of at least one BORG inhibiting agent to the BORG overexpressing cancer cells of the subject.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventor: Saba Valadkhan
  • Publication number: 20120183511
    Abstract: A method of transdifferentiating a non-neuronal mammalian cell into a neuronal cell including transfecting the non-neuronal non-terminally differentiated mammalian cell with a nucleic acid that promotes the transdifferentiation of the cell into a neuronal cell, wherein the nucleic acid is substantially homologous to BORG RNA.
    Type: Application
    Filed: September 16, 2010
    Publication date: July 19, 2012
    Inventors: Saba Valadkhan, Fereshteh Jahaniani Kenari